MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Artiva Biotherapeutics (NASDAQ: ARTV)*
Organization & Developments: Artiva
Parents
Artiva Biotherapeutics (NASDAQ: ARTV)*
Children
2020: Out of jobs, a pair of early cell therapy executives went to Seoul, came back with a new company, $70M and a plan to leapfrog natural killer competitors
2025: Natural killer cells, a rising alternative to CAR-T cell therapy
Jumps
*Key People: Artiva
Finance & Acquisition: Artiva